This is a theoretical question without direct research to support it
Abbreviations EOC: Epithelial ovarian cancer OCCC: Ovarian clear cell carcinoma OEC: Endometrioid carcinoma ARID1A: AT-rich interactive domain-containing protein 1A PIK3CA: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha PTEN: Phosphatase and tensin homolog KRAS: KRAS proto-oncogene TP53: Tumor protein p53 EAOC: Endometriosis-associated ovarian cancer SIR: Standardized incidence ratio CI: Confidence interval ER: Estrogen receptor beta ER: Estrogen receptor alpha BDNF: Brain-derived neurotrophic factor TrkB: Tropomyosin receptor kinase B (NTRK2) IHC: Immunohistochemistry ERE: Estrogen response element RTK: Receptor tyrosine kinase PI3K: Phosphatidylinositol 3-kinase AKT: Protein kinase B EMT: Epithelialmesenchymal transition TME: Tumor microenvironment MAPK/ERK: Mitogen-activated protein kinase/extracellular signal-regulated kinase JAK/STAT: Janus kinase/signal transducer and activator of transcription OR: Odds ratio HR: Hazard ratio IC50: Half maximal inhibitory concentration p-AKT: Phosphorylated AKT p-ERK: Phosphorylated ERK mTOR: Mechanistic target of rapamycin FFPE: Formalin-fixed, paraffin-embedded References Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG
This peptide is referenced in scientific literature for studies involving telomere regulation, DNA stability, circadian rhythm signaling, and cellular mechanisms
Note that peptide therapies are usually administered via injectable ways because it allows the Epitalon to enter your bloodstream within no time
